MPRI ARCTIC FRONT ADVANCE PRO¿ CARDIAC CRYOABLATION CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
|
Back to Search Results |
|
Model Number AFAPRO28 |
Device Problems
Leak/Splash (1354); Mechanical Problem (1384)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 10/30/2023 |
Event Type
malfunction
|
Event Description
|
It was reported that during a cryo ablation procedure, air was seen in the manifold flush line.The copilot connector was replaced and the line was flushed, but the issue persisted.It was then reported that a crack was in the flush line connector of the balloon catheter.The balloon catheter was replaced which resolved the issue.The case was completed with cryo. no patient complications have been reported as a result of this event.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Product event summary: the data files and the afapro28 balloon catheter with lot number 09926 were returned and analyzed.The patient data file returned showed 18 applications were performed on the event date.Application one to ten were performed using afapro28 balloon catheter with lot number 09926.No system notices were triggered during these applications.Application 11 to 18 were performed using afapro28 balloon catheter with lot number 08852.No system notices were triggered during these applications.The afapro28 balloon catheter with lot number 09926 was visually inspected.The external visual inspection of the electrical handle segment showed excessive adhesive on the exterior of the guidewire luer.The balloon catheter was recognized and passed the electrical integrity verifications and performance test.The balloon catheter completed the inflation, ablation, and thawing phases with no console system notices generated.All pressure and flow were in range and temperature curve had no oscillation or overshoot.The adhesive from the guidewire luer was removed from the balloon catheter.The balloon catheter was flushed successively, and no air bubbles were observed.In conclusion, the reported air ingress and broken luer issues were not confirmed through analysis and the balloon catheter failed the returned product inspection due to excessive adhesive on the exterior of the guidewire luer.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|